EUVIMEDEUVIMED entdecken
Crossref

Stimuli-Responsive mRNA Vaccines to Induce Robust CD8 + T Cell Response via ROS-Mediated Innate Immunity Boosting

Linying Dong, Xuqian Deng, Yan Li, Xiaolan Zhu, Mingbo Shu, Jingyi Chen, Huacheng Luo, Keli An, Ming Cheng, Penghui Zhang iD, Weihong Tan iD

Journal of the American Chemical Society · 2024

DOI: 10.1021/jacs.4c04331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2024. Verfasst von Linying Dong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Faculty of Medicine, Tianjin University, Tianjin 300072, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Immunity, Innate, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesImmunity, InnateCD8-Positive T-LymphocytesAnimalsMicemRNA VaccinesCancer VaccinesRNA, MessengerHumansMice, Inbred C57BL

Substanzen

Reactive Oxygen SpeciesmRNA VaccinesCancer VaccinesRNA, Messenger

Autor:innen und Institutionen

  • Medical School, Faculty of Medicine, Tianjin University, Tianjin 300072, China.
  • Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China.
  • Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.
  • Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.

ORCID-Profile: Penghui Zhang, Weihong Tan

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Scientific Experiment Center, Hangzhou Institute of Medicine, Chinese Academy of Sciences
  • Zhejiang Leading Innovation and Entrepreneurship Team

Zitieren

APA

Dong, L., Deng, X., Li, Y., Zhu, X., Shu, M., Chen, J., Luo, H., An, K., Cheng, M., Zhang, P., & Tan, W. (2024). Stimuli-Responsive mRNA Vaccines to Induce Robust CD8 + T Cell Response via ROS-Mediated Innate Immunity Boosting. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c04331

Vancouver

Dong L, Deng X, Li Y, Zhu X, Shu M, Chen J, et al. Stimuli-Responsive mRNA Vaccines to Induce Robust CD8 + T Cell Response via ROS-Mediated Innate Immunity Boosting. Journal of the American Chemical Society. 2024. doi:10.1021/jacs.4c04331

BibTeX
@article{Dong2024,
  author = {Dong, Linying and Deng, Xuqian and Li, Yan and Zhu, Xiaolan and Shu, Mingbo and Chen, Jingyi and Luo, Huacheng and An, Keli and Cheng, Ming and Zhang, Penghui and Tan, Weihong},
  title = {Stimuli-Responsive mRNA Vaccines to Induce Robust CD8 + T Cell Response via ROS-Mediated Innate Immunity Boosting},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  doi = {10.1021/jacs.4c04331}
}
Kostenlos starten →